Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-25 @ 8:55 PM
NCT ID: NCT00733356
Description: adverse event data were collected in weekly visits based on spontaneous parent report until final study data. Any ongoing adverse events were again assessed at the 30 day follow-up call.
Frequency Threshold: 5
Time Frame: 12 weeks from initial screening through 30 days of follow-up.
Study: NCT00733356
Study Brief: The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ADHD With Vyvanse Treatment All enrolled subjects will be titrated to an effective dose of vyvanse. Reading abilities were tested in a modified lab school day. None None 0 26 0 26 View
Serious Events(If Any):
Other Events(If Any):